Annals of Family Medicine

NOVEMBER 20, 2024

Study design, setting, population Qualitative study using semi-structured interviews with 32/326 Ontarians participating in the ARC-211 randomized control trial (2019-2020).

Patients 130

Patients Community Patient-Centered Referral 130

Physician's Weekly

JUNE 14, 2025

Researchers conducted a retrospective study to examine the prevalence and risk factors of coercive measures in open inpatient wards of a Swiss university psychiatric hospital. They analyzed the use of seclusion and restraint from 2017 to 2019.

Referral 52

Referral Mental Health Hospital Diagnose 52

The Clinical Problem Solvers

MARCH 14, 2025

There are a growing number of Child Psychiatric Access Programs, including one in Massachusetts, which provide quick access to psychiatric consultation and facilitates referrals for accessing ongoing behavioral health care. 2019-1187 Lindsey MA, Brown DR, Cunningham M. Published December 17, 2019. Pediatrics. doi: 10.1542/peds.2019-1187

Mental Health 52

Mental Health Community Patient-Centered Hospital 52

CDOCS

MARCH 15, 2021

The question often becomes, how can we overcome this disparity in attitudes towards our professional network of referrals? link] Dated June 2019. Our patients&rsquo; thoughts focus on the time, pain, and money regarding the procedure they need. Accessed February 2021.</span></p>

Patients 52

Patients Finance Education Utilities 52

FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. § EKRA Issue. 18 US.C. § 18 U.S.C. §

Lab Testing 52

Lab Testing Referral Individual Patient-Centered 52

FDA Law Blog

NOVEMBER 6, 2022

In June 2019, Pfizer sought an OIG advisory opinion to ensure that its proposal would not run afoul of federal law. Eligible patients would be responsible for only $35 per month, and Pfizer would cover the rest of the approximately $13,000 annual copay. The Medicare program would pay most of the remaining $225,000 in annual cost.

Manufacturing 83

Manufacturing Patient-Centered Healthcare Utilities 83

FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. § EKRA Issue. 18 US.C. § 18 U.S.C. §

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40